Instituto de Investigación, Innovación y Tecnología Educativas (UNIR iTED)
Facultad
Centro Nacional de Epidemiología
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro Nacional de Epidemiología (27)
2017
-
CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: A multinational, multicohort European study
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 10, pp. 2869-2878
2016
-
Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013
Journal of Infection, Vol. 72, Núm. 5, pp. 587-596
2015
-
Transmitted drug resistance to rilpivirine in newly diagnosed antiretroviral naive adults
Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 104.e1-104.e5
-
Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012)
Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 105.e1-105.e5
2014
-
Incidence of Hepatitis C Virus (HCV) in a multicenter cohort of HIV-positive patients in Spain 2004-2011: Increasing rates of HCV diagnosis but not of HCV seroconversions
PLoS ONE, Vol. 9, Núm. 12
-
Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries
AIDS, Vol. 28, Núm. 16, pp. 2461-2473
-
Tuberculosis in a cohort of HIV-positive patients: Epidemiology, clinical practice and treatment outcomes
International Journal of Tuberculosis and Lung Disease, Vol. 18, Núm. 6
2013
-
Risk, predictors, and mortality associated with non-AIDS events in newly diagnosed HIV-infected patients: Role of antiretroviral therapy
AIDS, Vol. 27, Núm. 2, pp. 181-189
2012
2011
-
HBV primary drug resistance in newly diagnosed HIV-HBV-coinfected individuals in Spain
Antiviral Therapy, Vol. 16, Núm. 4, pp. 585-589
2009
-
Delayed diagnosis of HIV infection in a multicenter cohort: Prevalence, risk factors, response to HAART and impact of mortality
Current HIV Research, Vol. 7, Núm. 2, pp. 224-230
-
Injecting, sexual risk behaviors and HIV infection in young cocaine and heroin users in Spain project itinere group
European Addiction Research, Vol. 15, Núm. 3, pp. 171-178
-
The role of injection versus socioeconomic factors in hepatitis A virus infection among young heroin users: Implications for vaccination policies
Vaccine, Vol. 27, Núm. 20, pp. 2674-2679
2008
-
Hepatitis B vaccination: An unmet challenge in the era of harm reduction programs
Journal of Substance Abuse Treatment, Vol. 34, Núm. 4, pp. 398-406
-
Prevalence of and risk factors for hepatitis B virus infection among street-recruited young injection and non-injection heroin users in Barcelona, Madrid and Seville
European Addiction Research, Vol. 14, Núm. 3, pp. 116-124
2007
-
Changes in the incidence of tuberculosis in a cohort of HIV-seroconverters before and after the introduction of HAART
AIDS, Vol. 21, Núm. 18, pp. 2521-2527
-
Cohorte RIS de pacientes con infección por VIH sin tratamiento antirretroviral previo (CoRIS): Metodología y primeros resultados
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 25, Núm. 1, pp. 23-31
-
Poor validity of self-reported HBV vaccination among young heroin users in Spain supports the policy "don't ask, draw a blood sample, vaccinate and try to schedule another visit"
Journal of Clinical Virology, Vol. 38, Núm. 1, pp. 87-90
-
Prevalence of HIV infection among young adult injecting and non-injecting heroin users in Spain in the era of harm reduction programmes: Gender differences and other related factors
Epidemiology and Infection, Vol. 135, Núm. 4, pp. 592-603
2006
-
HTLV infection among young injection and non-injection heroin users in Spain: Prevalence and correlates
Journal of Clinical Virology, Vol. 35, Núm. 3, pp. 244-249